series-a
Stage
2
Investors
About
Darktrace develops AI-driven cybersecurity software that detects, investigates, and autonomously responds to threats across enterprise, cloud, and industrial networks. Its products include the Enterprise Immune System and the Antigena autonomous response technology.
Explore Darktrace's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.